Royalty Pharma plc (RPRX) Revenue 2018–2025
Royalty Pharma plc (RPRX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$2.4BFY2025 · since FY2018: $1.8B → $2.4B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.4B | +5.1% |
| FY2024 | $2.3B | -3.9% |
| FY2023 | $2.4B | +5.2% |
| FY2022 | $2.2B | -2.3% |
| FY2021 | $2.3B | +7.9% |
| FY2020 | $2.1B | +17.0% |
| FY2019 | $1.8B | +1.1% |
| FY2018 | $1.8B | — |
Source: SEC XBRL filings · For reference only · Not investment advice